Teleflex (TFX)
(Delayed Data from NYSE)
$206.71 USD
-4.46 (-2.11%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $206.94 +0.23 (0.11%) 5:40 PM ET
4-Sell of 5 4
B Value D Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
TFX 206.71 -4.46(-2.11%)
Will TFX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for TFX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TFX
Teleflex (TFX) Debuts the New Unified UroLift 2 System With ATC
Is ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) a Strong ETF Right Now?
TFX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Retain Teleflex (TFX) Stock for Now
Should ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) Be on Your Investing Radar?
Teleflex (TFX) Q4 Earnings Top Estimates, Operating Margin Falls
Other News for TFX
Teleflex Announces First Quarter 2024 Earnings Conference Call Information
RBC Capital Sticks to Its Buy Rating for Teleflex (TFX)
(TFX) - Analyzing Teleflex's Short Interest
DDL Expands its Offerings with Addition of Consulting Services Focused on Packaging Process Development
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types